Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/49450
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2019-12-06T07:55:50Z | - |
dc.date.available | 2019-12-06T07:55:50Z | - |
dc.date.issued | 2019-10 | - |
dc.identifier.citation | Grech, V. (2019). Towards evidence-based medical cannabis. Malta Medical Journal, 31(2), 1-5. | en_GB |
dc.identifier.uri | https://www.um.edu.mt/library/oar/handle/123456789/49450 | - |
dc.description.abstract | Medical cannabis (MC) is at a crossroads. The MC industry needs evidence-based medicine to sell MC as there is still some residual stigma among the medical profession. Furthermore, evidence is needed in order to persuade doctors to prescribe. The requisite papers must be high quality research: double- blind, randomized control trials, systematic reviews and meta-analyses. As it is, MC currently incorporates relatively few commercial products, and those that are developed and marketed with standardized ingredients and with the requisite quality control (e.g. nabilone) have been welcomed by the medical community as they permit proper trials. At the time of writing, evidence for the usefulness of MC is limited and MC is associated with significant side effects. Clearly, new products and more clinical trials are required. Product development and trialing will take time and will cost money. There is clearly a knowledge gap must be bridged if MC is to ever be treated as medicine and routinely prescribed. MC must meet the same exacting standards of quality, effectiveness and safety of any other prescription drug or it risks being ignored or marginalized by the medical community. For all of these reasons, including the many unanswered questions, the MC industry constitutes an exciting and lucrative opportunity for Malta. | en_GB |
dc.language.iso | en | en_GB |
dc.publisher | University of Malta. Medical School | en_GB |
dc.rights | info:eu-repo/semantics/openAccess | en_GB |
dc.subject | Editorials | en_GB |
dc.subject | Cannabis -- Therapeutic use | en_GB |
dc.subject | Cannabis -- Research | en_GB |
dc.title | Towards evidence-based medical cannabis | en_GB |
dc.type | editorial | en_GB |
dc.rights.holder | The copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder. | en_GB |
dc.description.reviewed | N/A | en_GB |
dc.publication.title | Malta Medical Journal | en_GB |
dc.contributor.creator | Grech, Victor E. | - |
Appears in Collections: | MMJ, Volume 31, Issue 2 MMJ, Volume 31, Issue 2 Scholarly Works - FacM&SPae |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
MMJ31(2)Edi.pdf | 1.23 MB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.